TYPTF (Entropy Neurodynamics) Beginning Cash Position: $2.01 Mil (As of Dec. 2025)


What is Entropy Neurodynamics Beginning Cash Position?

Entropy Neurodynamics TYPTF Beginning Cash Position is $2.01 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Entropy Neurodynamics's Beginning Cash Position for the quarter that ended in Dec. 2025 was $2.01 Mil.

Entropy Neurodynamics's quarterly Beginning Cash Position declined from Dec. 2024 ($3.40 Mil) to Jun. 2025 ($1.84 Mil) but then increased from Jun. 2025 ($1.84 Mil) to Dec. 2025 ($2.01 Mil).

Entropy Neurodynamics's annual Beginning Cash Position declined from Jun. 2022 ($8.94 Mil) to Jun. 2023 ($3.25 Mil) but then increased from Jun. 2023 ($3.25 Mil) to Jun. 2025 ($3.47 Mil).

Entropy Neurodynamics Beginning Cash Position Related Terms

Entropy Neurodynamics Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Entropy Neurodynamics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entropy Neurodynamics Beginning Cash Position Chart

Entropy Neurodynamics Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun25
Beginning Cash Position
Get a 7-Day Free Trial 3.05 1.33 8.94 3.25 3.47

Entropy Neurodynamics Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.13 1.10 3.40 1.84 2.01

Entropy Neurodynamics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $2.01 Mil mean?
Entropy Neurodynamics (TYPTF) has a Beginning Cash Position of $2.01 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Entropy Neurodynamics and its competitors.
Is Entropy Neurodynamics' Beginning Cash Position too high?
Entropy Neurodynamics' current Beginning Cash Position is $2.01 Mil.
How does Entropy Neurodynamics' Beginning Cash Position compare to VRTX and REGN?
Entropy Neurodynamics' Beginning Cash Position of $2.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Entropy Neurodynamics and its competitors. Entropy Neurodynamics's current Beginning Cash Position is $2.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entropy Neurodynamics stock overvalued right now?
Based on GuruFocus' analysis, Entropy Neurodynamics (TYPTF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 12% above its estimated fair value. The current Beginning Cash Position is $2.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Entropy Neurodynamics (TYPTF), the current Beginning Cash Position is $2.01 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entropy Neurodynamics Business Description

Other Exchanges ENP:Australia
Address 117 Camberwell Road,, Hawthorn East, Suite 1.01, Camberwell, Melbourne, VIC, AUS, 3123
Entropy Neurodynamics Ltd is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. The company's lead program is TRP-8803. TRP-8803 is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) with potential to alleviate numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe.